GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy

Clinical trial NCT04601402 · COMPLETED

Trial details

NCT number: NCT04601402
Sponsor: Genome & Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Non Small Cell Lung Cancer Squamous Cell Carcinoma of Head and Neck Urothelial Carcinoma

Start date: 2020-10-26
Primary completion: 2023-01-11
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.